TMCI
TREACE MEDICAL CONCEPTS, INC.
Company overview
- Market capitalization
- $291.35M
- Employees
- 450
- Latest publication
- 2026-09-29
About TREACE MEDICAL CONCEPTS, INC.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 45,376,000USD | 47,198,000USD | 62,519,000USD | 50,214,000USD | 47,387,000USD | 52,570,000USD | 68,708,000USD | 45,086,000USD |
| Cost Of Revenue | 9,769,000USD | 9,791,000USD | 12,118,000USD | 10,508,000USD | 9,635,000USD | 10,677,000USD | 13,231,000USD | 8,954,000USD |
| Gross Profit | 35,607,000USD | 37,407,000USD | 50,401,000USD | 39,706,000USD | 37,752,000USD | 41,893,000USD | 55,477,000USD | 36,132,000USD |
| Research Development | 4,376,000USD | 4,622,000USD | 4,542,000USD | 4,680,000USD | 5,498,000USD | 5,562,000USD | 5,210,000USD | 4,963,000USD |
| Selling General Administrative | 15,249,000USD | 16,177,000USD | 14,528,000USD | 16,280,999USD | 16,144,000USD | 15,791,000USD | 13,612,000USD | 13,528,000USD |
| Selling And Marketing Expenses | 30,940,000USD | 33,775,000USD | 37,253,000USD | 33,421,000USD | 33,084,000USD | 36,122,000USD | 36,859,000USD | 32,775,000USD |
| General And Administrative Expenses | 15,249,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 50,565,000USD | 54,574,000USD | 56,323,000USD | 55,382,000USD | 54,726,000USD | 57,475,000USD | 55,681,000USD | 51,266,000USD |
| Operating Income | -14,958,000USD | -17,167,000USD | -5,922,000USD | -15,676,000USD | -16,974,000USD | -15,582,000USD | -204,000USD | -15,134,000USD |
| Total Other Income Expense Net | -915,000USD | -794,000USD | -3,472,000USD | -612,000USD | -424,000USD | -340,000USD | -297,000USD | -226,000USD |
| Interest Expense | 1,562,000USD | 1,570,000USD | 1,350,000USD | 1,338,000USD | 1,321,000USD | 1,311,000USD | 1,314,000USD | 1,313,000USD |
| Net Income | -15,873,000USD | -17,961,000USD | -9,394,000USD | -16,288,000USD | -17,398,000USD | -15,922,000USD | -501,000USD | -15,360,000USD |
| Interest Income | — | 501,000USD | 527,000USD | 634,000USD | 775,000USD | 841,000USD | 899,000USD | 1,067,000USD |
| Net Interest Income | — | -1,069,000USD | -823,000USD | -704,000USD | -546,000USD | -470,000USD | -415,000USD | -246,000USD |
| Income Before Tax | — | -17,961,000USD | -9,394,000USD | -16,288,000USD | -17,398,000USD | -15,922,000USD | -501,000USD | -15,360,000USD |
| Net Income From Continuing Ops | — | -17,961,000USD | -9,394,000USD | -16,288,000USD | -17,398,000USD | -15,922,000USD | -501,000USD | -15,360,000USD |
| Ebit | — | -17,167,000USD | -8,044,000USD | -14,950,000USD | -16,077,000USD | -14,611,000USD | 813,000USD | -14,047,000USD |
| Ebitda | — | -16,268,000USD | -5,163,000USD | -12,172,000USD | -13,501,000USD | -12,150,000USD | 3,050,000USD | -11,890,000USD |
| Depreciation And Amortization | — | 899,000USD | 2,881,000USD | 2,778,000USD | 2,576,000USD | 2,461,000USD | 2,237,000USD | 2,157,000USD |
| Reconciled Depreciation | — | 899,000USD | 2,808,000USD | 2,778,000USD | 2,576,000USD | 2,461,000USD | 2,237,000USD | 2,157,000USD |
| Unclassified Operating Expenses | — | — | — | 1,000,001USD | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | -2,157,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 212,690,000USD | 209,357,000USD | 187,118,000USD | 141,838,000USD | 94,419,000USD | 57,365,000USD | 39,416,000USD |
| Cost Of Revenue | 42,938,000USD | 41,093,000USD | 35,181,000USD | 27,523,000USD | 16,888,000USD | 12,470,000USD | 7,631,000USD |
| Gross Profit | 169,752,000USD | 168,264,000USD | 151,937,000USD | 114,315,000USD | 77,531,000USD | 44,895,000USD | 31,785,000USD |
| Research Development | 20,282,000USD | 20,589,000USD | 15,440,000USD | 13,584,000USD | 10,204,000USD | 5,847,000USD | 5,070,000USD |
| Selling General Administrative | 62,744,000USD | 55,720,000USD | 47,031,000USD | 32,999,000USD | 18,432,000USD | 6,539,000USD | 4,464,000USD |
| Selling And Marketing Expenses | 140,880,000USD | 147,643,000USD | 140,894,000USD | — | 65,405,000USD | 31,654,000USD | 25,786,000USD |
| Total Operating Expenses | 223,906,000USD | 223,952,000USD | 203,365,000USD | 149,159,000USD | 94,041,000USD | 44,040,000USD | 35,320,000USD |
| Operating Income | -54,154,000USD | -55,688,000USD | -51,428,000USD | -34,844,000USD | -16,510,000USD | 855,000USD | -3,535,000USD |
| Interest Income | 2,777,000USD | 4,877,000USD | 5,367,000USD | 910,000USD | 18,000USD | — | 111,000USD |
| Interest Expense | 5,320,000USD | 5,256,000USD | 5,167,000USD | 4,398,000USD | 4,060,000USD | 4,523,000USD | 841,000USD |
| Net Interest Income | -2,543,000USD | -379,000USD | 193,000USD | -3,488,000USD | -4,042,000USD | -4,523,000USD | -730,000USD |
| Income Before Tax | -59,002,000USD | -55,743,000USD | -49,527,000USD | -42,815,000USD | -20,552,000USD | -3,668,000USD | -4,265,000USD |
| Net Income | -59,002,000USD | -55,743,000USD | -49,527,000USD | -42,815,000USD | -20,552,000USD | -3,668,000USD | -4,265,000USD |
| Net Income From Continuing Ops | -59,002,000USD | -55,743,000USD | -47,658,000USD | -42,842,000USD | -20,552,000USD | -3,668,000USD | -4,265,000USD |
| Ebit | -53,682,000USD | -50,487,000USD | -44,360,000USD | -38,417,000USD | -16,492,000USD | 855,000USD | -3,424,000USD |
| Ebitda | -43,182,000USD | -42,068,000USD | -39,008,000USD | -36,284,000USD | -15,807,000USD | 2,065,000USD | -2,631,000USD |
| Depreciation And Amortization | 10,500,000USD | 8,419,000USD | 5,352,000USD | 2,133,000USD | 685,000USD | 1,210,000USD | 793,000USD |
| Reconciled Depreciation | 10,623,000USD | 8,419,000USD | 4,500,000USD | 2,133,000USD | 685,000USD | 1,210,000USD | 793,000USD |
| Total Other Income Expense Net | -4,848,000USD | -55,000USD | 1,901,000USD | -7,971,000USD | -4,042,000USD | -4,523,000USD | -730,000USD |
| Income Tax Expense | — | — | 5,184,105USD | 4,483,000USD | 4,060,000USD | 2,777,000USD | 841,000USD |
| Unclassified Operating Expenses | — | — | — | 102,576,000USD | — | — | — |
| Non Operating Income Net Other | — | — | — | -7,998,000USD | -4,042,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -42,815,000USD | -20,748,000USD | -4,308,000USD | -4,905,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 181,055,000USD | 184,102,000USD | 190,581,000USD | 196,591,000USD | 206,443,000USD | 205,846,000USD | 217,094,000USD | 212,924,000USD |
| Cash And Equivalents | 12,610,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 45,619,000USD | 51,854,000USD | 48,367,000USD | 57,416,000USD | 69,289,000USD | 76,089,000USD | 75,677,000USD | 82,799,000USD |
| Short Term Investments | 33,009,000USD | 42,310,000USD | 37,659,000USD | 49,730,000USD | 61,237,000USD | 62,717,000USD | 64,327,000USD | 70,689,000USD |
| Total Current Assets | 120,454,000USD | 123,471,000USD | 132,054,000USD | 137,997,000USD | 147,602,000USD | 149,437,000USD | 161,402,000USD | 157,602,000USD |
| Other Current Assets | 6,561,000USD | 4,893,000USD | 5,501,000USD | 6,198,000USD | 5,583,000USD | 4,298,000USD | 5,667,000USD | 7,015,000USD |
| Other Non Current Assets | 1,501,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 113,318,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 41,496,000USD | 34,491,000USD | 30,635,000USD | 40,908,000USD | 41,900,000USD | 33,180,000USD | 34,925,000USD | 38,263,000USD |
| Other Current Liabilities | 6,281,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 2,689,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 67,737,000USD | 77,191,000USD | 87,332,000USD | 89,187,000USD | 97,615,000USD | 105,341,000USD | 112,892,000USD | 104,906,000USD |
| Total Equity Including Noncontrolling Interest | 67,737,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 56,042,000USD | 55,820,000USD | 55,583,000USD | 53,529,000USD | 53,454,000USD | 53,380,000USD | 53,306,000USD | 53,231,000USD |
| Net Receivables | 28,732,000USD | 30,358,000USD | 42,155,000USD | 32,959,000USD | 30,333,000USD | 31,110,000USD | 40,803,000USD | 24,177,000USD |
| Inventory | 39,542,000USD | 36,366,000USD | 36,031,000USD | 41,424,000USD | 42,397,000USD | 37,940,000USD | 39,255,000USD | 43,611,000USD |
| Property Plant Equipment Net | 39,635,000USD | 39,434,000USD | 37,366,000USD | 37,803,000USD | 37,750,000USD | 35,370,000USD | 34,395,000USD | 33,737,000USD |
| Goodwill | 12,815,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 6,650,000USD | 6,887,000USD | 7,125,000USD | 7,362,000USD | 7,600,000USD | 7,837,000USD | 8,075,000USD | 8,312,000USD |
| Accounts Payable | 16,061,000USD | 13,537,000USD | 6,726,000USD | 16,103,000USD | 19,959,000USD | 13,223,000USD | 10,522,000USD | 18,649,000USD |
| Short Term Debt | 388,000USD | — | — | 3,913,000USD | 3,203,000USD | 2,076,000USD | 413,000USD | 403,000USD |
| Common Stock | 65,000USD | 65,000USD | 64,000USD | 64,000USD | 63,000USD | 63,000USD | 62,000USD | 62,000USD |
| Retained Earnings | -282,826,000USD | -266,953,000USD | -248,992,000USD | -239,598,000USD | -223,310,000USD | -205,912,000USD | -189,990,000USD | -189,489,000USD |
| Accumulated Other Comprehensive Income | -52,000USD | -26,000USD | 72,000USD | 83,000USD | 50,000USD | 57,000USD | 97,000USD | 191,000USD |
| Total Liab | — | 106,911,000USD | 103,249,000USD | 107,404,000USD | 108,828,000USD | 100,505,000USD | 104,202,000USD | 108,018,000USD |
| Other Current Liab | — | 20,954,000USD | 23,909,000USD | 20,892,000USD | 18,738,000USD | 17,881,000USD | 23,990,000USD | 19,211,000USD |
| Capital Stock | — | 65,000USD | 64,000USD | 64,000USD | 63,000USD | 63,000USD | 62,000USD | 62,000USD |
| Good Will | — | 12,815,000USD | 12,815,000USD | 12,815,000USD | 12,815,000USD | 12,815,000USD | 12,815,000USD | 12,815,000USD |
| Cash | — | 9,544,000USD | 10,708,000USD | 7,686,000USD | 8,052,000USD | 13,372,000USD | 11,350,000USD | 12,110,000USD |
| Net Debt | — | 4,007,000USD | 3,274,000USD | 62,686,000USD | 62,042,000USD | 55,992,000USD | 58,303,000USD | 58,011,000USD |
| Short Long Term Debt | — | 1,776,000USD | 1,745,000USD | 1,798,000USD | 1,113,000USD | 45,000USD | — | — |
| Short Long Term Debt Total | — | 13,551,000USD | 13,982,000USD | 70,372,000USD | 70,094,000USD | 69,364,000USD | 69,653,000USD | 70,121,000USD |
| Property Plant Equipment Gross | — | 63,371,000USD | 61,235,000USD | 59,580,000USD | 57,330,000USD | 52,924,000USD | 49,700,000USD | 47,791,000USD |
| Common Stock Shares Outstanding | — | 64,592,681shares | 63,860,088shares | 63,515,372shares | 63,006,891shares | 62,661,447shares | 62,340,603shares | 62,229,463shares |
| Non Current Assets Total | — | 60,631,000USD | 58,527,000USD | 58,594,000USD | 58,841,000USD | 56,409,000USD | 55,692,000USD | 55,322,000USD |
| Non Current Liabilities Total | — | 72,420,000USD | 72,614,000USD | 66,496,000USD | 66,928,000USD | 67,325,000USD | 69,277,000USD | 69,755,000USD |
| Non Current Liabilities Other | — | 3,049,000USD | 3,049,000USD | 37,000USD | 37,000USD | 37,000USD | 37,000USD | 37,000USD |
| Non Currrent Assets Other | — | 1,495,000USD | 1,221,000USD | 614,000USD | 676,000USD | 387,000USD | 407,000USD | 458,000USD |
| Net Working Capital | — | 88,980,000USD | 101,419,000USD | 97,089,000USD | 105,702,000USD | 116,257,000USD | 126,477,000USD | 119,339,000USD |
| Unclassified Current Liabilities | — | -1,776,000USD | -1,745,000USD | -1,798,000USD | -1,113,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 13,551,000USD | 13,982,000USD | 12,930,000USD | 13,437,000USD | 13,908,000USD | 15,934,000USD | 16,487,000USD |
| Unclassified Equity | — | 344,040,000USD | 336,124,000USD | 328,574,000USD | 320,749,000USD | 311,070,000USD | 302,661,000USD | 294,080,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -403,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 190,581,000USD | 217,094,000USD | 251,907,000USD | 159,024,000USD | 140,821,000USD | 41,807,000USD | 29,716,000USD |
| Intangible Assets | 7,125,000USD | 8,075,000USD | 9,025,000USD | — | — | — | — |
| Other Current Assets | 5,501,000USD | 5,667,000USD | 7,853,000USD | 3,624,000USD | 3,010,000USD | 593,000USD | 458,000USD |
| Total Liab | 103,249,000USD | 104,202,000USD | 113,969,000USD | 98,495,000USD | 47,748,000USD | 41,031,000USD | 26,555,000USD |
| Total Stockholder Equity | 87,332,000USD | 112,892,000USD | 137,938,000USD | 60,529,000USD | 93,073,000USD | 776,000USD | 3,161,000USD |
| Other Current Liab | 23,909,000USD | 23,990,000USD | 31,794,000USD | 21,238,000USD | 14,154,000USD | 7,545,000USD | 6,401,000USD |
| Common Stock | 64,000USD | 62,000USD | 62,000USD | 55,000USD | 45,000USD | 28,000USD | 28,000USD |
| Capital Stock | 64,000USD | 62,000USD | 62,000USD | 55,000USD | 45,000USD | 7,963,000USD | 7,963,000USD |
| Retained Earnings | -248,992,000USD | -189,990,000USD | -134,247,000USD | -84,720,000USD | -41,905,000USD | -21,353,000USD | -17,686,000USD |
| Good Will | 12,815,000USD | 12,815,000USD | 12,815,000USD | 0USD | — | — | — |
| Cash | 10,708,000USD | 11,350,000USD | 12,982,000USD | 19,473,000USD | 105,833,000USD | 18,079,000USD | 12,139,000USD |
| Cash And Short Term Investments | 48,367,000USD | 75,677,000USD | 123,198,000USD | 81,252,000USD | 105,833,000USD | 18,079,000USD | 12,139,000USD |
| Total Current Assets | 132,054,000USD | 161,402,000USD | 198,359,000USD | 133,402,000USD | 137,972,000USD | 40,978,000USD | 28,570,000USD |
| Total Current Liabilities | 30,635,000USD | 34,925,000USD | 45,033,000USD | 30,245,000USD | 18,210,000USD | 11,598,000USD | 7,332,000USD |
| Net Debt | 3,274,000USD | 58,303,000USD | 57,321,000USD | 49,116,000USD | -76,468,000USD | 12,898,000USD | 7,084,000USD |
| Short Long Term Debt | 1,745,000USD | — | — | — | — | 1,788,000USD | — |
| Short Long Term Debt Total | 13,982,000USD | 69,653,000USD | 70,303,000USD | 68,589,000USD | 29,365,000USD | 30,977,000USD | 19,223,000USD |
| Long Term Debt | 55,583,000USD | 53,306,000USD | 53,008,000USD | 52,711,000USD | 29,365,000USD | 29,189,000USD | 19,223,000USD |
| Short Term Investments | 37,659,000USD | 64,327,000USD | 110,216,000USD | 61,779,000USD | 0USD | — | — |
| Net Receivables | 42,155,000USD | 40,803,000USD | 38,063,000USD | 29,196,000USD | 18,568,000USD | 14,486,000USD | 10,411,000USD |
| Inventory | 36,031,000USD | 39,255,000USD | 29,245,000USD | 19,330,000USD | 10,561,000USD | 7,820,000USD | 5,562,000USD |
| Accounts Payable | 6,726,000USD | 10,522,000USD | 11,835,000USD | 8,668,000USD | 4,056,000USD | 2,265,000USD | 931,000USD |
| Property Plant Equipment Net | 37,366,000USD | 34,395,000USD | 31,562,000USD | 25,476,000USD | 2,849,000USD | 829,000USD | 1,146,000USD |
| Property Plant Equipment Gross | 61,235,000USD | 49,700,000USD | 40,310,000USD | 25,476,000USD | 2,849,000USD | 829,000USD | 1,146,000USD |
| Accumulated Other Comprehensive Income | 72,000USD | 97,000USD | 163,000USD | -27,000USD | — | -2,636,000USD | -1,641,000USD |
| Common Stock Shares Outstanding | 63,269,003shares | 62,112,037shares | 60,852,153shares | 55,276,834shares | 54,181,082shares | 51,165,912shares | 51,165,912shares |
| Non Current Assets Total | 58,527,000USD | 55,692,000USD | 53,548,000USD | 25,622,000USD | 2,849,000USD | 829,000USD | 1,146,000USD |
| Non Current Liabilities Total | 72,614,000USD | 69,277,000USD | 68,936,000USD | 68,250,000USD | 29,538,000USD | 29,433,000USD | 19,223,000USD |
| Non Current Liabilities Other | 3,049,000USD | 37,000USD | 37,000USD | 15,539,000USD | — | -1,000USD | — |
| Non Currrent Assets Other | 1,221,000USD | 407,000USD | 146,000USD | 146,000USD | -2,849,000USD | -829,000USD | -1,146,000USD |
| Net Working Capital | 101,419,000USD | 126,477,000USD | 153,326,000USD | 103,157,000USD | 119,762,000USD | 29,380,000USD | 21,238,000USD |
| Unclassified Current Liabilities | -1,745,000USD | — | — | — | — | -9,332,000USD | — |
| Unclassified Non Current Liabilities | 13,982,000USD | 15,934,000USD | 15,891,000USD | — | — | — | — |
| Unclassified Equity | 336,124,000USD | 302,661,000USD | 271,898,000USD | 145,166,000USD | 134,888,000USD | 16,774,000USD | 14,497,000USD |
| Short Term Debt | — | 413,000USD | 1,404,000USD | 339,000USD | — | 1,788,000USD | — |
| Other Assets | — | — | — | 146,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 60,529,000USD | 93,073,000USD | -7,159,000USD | -4,774,000USD |
| Deferred Long Term Liab | — | — | — | — | 173,000USD | — | — |
| Other Liab | — | — | — | — | — | -1,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | 7,544,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,787,000USD |
| Stock Based Compensation | 14,497,000USD |
| Other Non Cash Items | -1,383,000USD |
| Change To Account Receivables | 13,180,000USD |
| Change To Inventory | -3,511,000USD |
| Change To Liabilities | 8,963,000USD |
| Change In Working Capital | 17,624,000USD |
| Operating Cash Flow | 2,542,000USD |
| Capital Expenditures | -5,263,000USD |
| Net Investments | 4,515,000USD |
| Investing Cash Flow | -748,000USD |
| Net Common Stock Issuance | -233,000USD |
| Unclassified Financing Cash Flow | 341,000USD |
| Financing Cash Flow | 108,000USD |
| Change In Cash | 1,902,000USD |
| End Cash Flow | 12,610,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,961,000USD | -9,394,000USD | -16,288,000USD | -17,398,000USD | -15,922,000USD | -501,000USD | -15,360,000USD | -21,206,000USD |
| Depreciation | 899,000USD | 2,881,000USD | 2,853,000USD | 2,462,000USD | 2,461,000USD | 2,237,000USD | 2,157,000USD | 2,116,000USD |
| Stock Based Compensation | 8,034,000USD | 7,555,000USD | 7,998,000USD | 9,577,000USD | 8,693,000USD | 8,555,000USD | 7,900,000USD | 6,740,000USD |
| Other Non Cash Items | 9,565,000USD | 4,042,000USD | -2,843,000USD | 819,000USD | 1,262,000USD | 2,514,000USD | -539,000USD | 2,431,000USD |
| Change To Account Receivables | 11,685,000USD | -9,518,000USD | -2,557,000USD | 696,000USD | 9,289,000USD | -17,192,000USD | 1,208,000USD | 2,476,000USD |
| Change To Inventory | -335,000USD | 5,393,000USD | 973,000USD | -4,457,000USD | 1,315,000USD | 4,356,000USD | -2,332,000USD | -5,419,000USD |
| Change In Working Capital | 14,731,000USD | -13,110,000USD | -812,000USD | 1,490,000USD | 7,704,000USD | -17,012,000USD | -6,000,000USD | -3,978,000USD |
| Total Cash From Operating Activities | 7,234,000USD | -8,026,000USD | -9,092,000USD | -3,050,000USD | 4,198,000USD | -4,207,000USD | -11,842,000USD | -13,897,000USD |
| Capital Expenditures | -3,062,000USD | -2,398,000USD | -2,809,000USD | -4,767,000USD | -3,543,000USD | -3,074,000USD | -2,863,000USD | -1,729,000USD |
| Free Cash Flow | 4,171,999USD | -10,424,000USD | -11,901,000USD | -7,817,000USD | 655,000USD | -7,281,000USD | -14,705,000USD | -15,626,000USD |
| Investments | -4,754,000USD | 12,064,000USD | 8,736,000USD | -3,257,000USD | -1,894,000USD | 3,421,000USD | 5,763,000USD | 22,433,000USD |
| Total Cashflows From Investing Activities | -7,816,000USD | 9,666,000USD | 8,736,000USD | -3,257,000USD | -1,894,000USD | 3,421,000USD | 5,763,000USD | 22,433,000USD |
| Total Cash From Financing Activities | -582,000USD | 1,382,000USD | -10,000USD | 987,000USD | -282,000USD | 26,000USD | 8,000USD | 311,000USD |
| Change In Cash | -1,164,000USD | 3,022,000USD | -366,000USD | -5,320,000USD | 2,022,000USD | -760,000USD | -6,071,000USD | 8,847,000USD |
| Begin Period Cash Flow | 10,708,000USD | 7,686,000USD | 8,052,000USD | 13,372,000USD | 11,350,000USD | 12,110,000USD | 18,181,000USD | 9,334,000USD |
| End Period Cash Flow | 9,544,000USD | 10,708,000USD | 7,686,000USD | 8,052,000USD | 13,372,000USD | 11,350,000USD | 12,110,000USD | 18,181,000USD |
| Other Cashflows From Financing Activities | -207,000USD | -75,000USD | 402,000USD | -14,000USD | -401,000USD | -31,000USD | 5,763,000USD | 311,000USD |
| Unclassified Operating Cash Flow | -8,034,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 1,457,000USD | — | 1,001,000USD | — | — | -5,992,000USD | — |
| Sale Purchase Of Stock | — | — | -412,000USD | — | — | — | 237,000USD | — |
| Other Cashflows From Investing Activities | — | — | 11,545,000USD | — | — | — | — | 24,162,000USD |
| Unclassified Investing Cash Flow | — | — | -8,736,000USD | 4,767,000USD | 3,543,000USD | 3,074,000USD | 2,863,000USD | -22,433,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -59,002,000USD | -55,743,000USD | -49,527,000USD | -42,815,000USD | -20,552,000USD | -3,668,000USD | -4,265,000USD |
| Depreciation | 10,500,000USD | 8,419,000USD | 5,352,000USD | 2,133,000USD | 685,000USD | 1,210,000USD | 793,000USD |
| Stock Based Compensation | 33,823,000USD | 30,603,000USD | 17,352,000USD | 8,111,000USD | 3,409,000USD | 919,000USD | 815,000USD |
| Other Non Cash Items | 7,293,000USD | 4,987,000USD | 1,991,000USD | 7,732,000USD | 176,000USD | 221,000USD | 292,000USD |
| Change To Account Receivables | -2,090,000USD | -5,687,000USD | -9,301,000USD | -11,039,000USD | -4,226,000USD | -4,291,000USD | -6,022,000USD |
| Change To Inventory | 3,224,000USD | -10,010,000USD | -9,848,000USD | -8,769,000USD | -3,088,000USD | -3,402,000USD | -2,813,000USD |
| Change In Working Capital | -8,584,000USD | -25,433,000USD | -9,743,000USD | -5,809,000USD | -1,330,000USD | -5,319,000USD | -5,308,000USD |
| Total Cash From Operating Activities | -15,970,000USD | -37,167,000USD | -34,575,000USD | -30,648,000USD | -17,193,000USD | -4,494,000USD | -7,673,000USD |
| Capital Expenditures | -13,517,000USD | -11,593,000USD | -11,458,000USD | -14,838,000USD | -2,705,000USD | -1,069,000USD | -1,211,000USD |
| Free Cash Flow | -29,487,000USD | -48,760,000USD | -46,033,000USD | -45,486,000USD | -19,898,000USD | -5,563,000USD | -8,884,000USD |
| Investments | 26,768,000USD | 35,375,000USD | -150,318,000USD | -61,680,000USD | -2,705,000USD | -1,069,000USD | -1,211,000USD |
| Total Cashflows From Investing Activities | 13,251,000USD | 35,375,000USD | -81,299,000USD | -76,518,000USD | -2,705,000USD | -1,069,000USD | -1,211,000USD |
| Net Borrowings | 59,310,000USD | 0USD | 0USD | -989,000USD | -1,788,000USD | 11,318,000USD | 20,000,000USD |
| Total Cash From Financing Activities | 2,077,000USD | 160,000USD | 109,383,000USD | 20,806,000USD | 107,652,000USD | 11,503,000USD | 19,739,000USD |
| Dividends Paid | 0USD | 0USD | 0USD | — | -7,935,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 0USD | 107,527,000USD | 107,527,000USD | 107,610,000USD | 0USD | 0USD |
| Change In Cash | -642,000USD | -1,632,000USD | -6,491,000USD | -86,360,000USD | 87,754,000USD | 5,940,000USD | 10,855,000USD |
| Begin Period Cash Flow | 11,350,000USD | 12,982,000USD | 19,473,000USD | 105,833,000USD | 18,079,000USD | 12,139,000USD | 1,284,000USD |
| End Period Cash Flow | 10,708,000USD | 11,350,000USD | 12,982,000USD | 19,473,000USD | 105,833,000USD | 18,079,000USD | 12,139,000USD |
| Other Cashflows From Financing Activities | -902,000USD | -268,000USD | -13,000USD | -989,000USD | 1,830,000USD | -179,000USD | -261,000USD |
| Unclassified Financing Cash Flow | -56,331,000USD | — | 109,409,000USD | 20,597,000USD | 107,610,000USD | — | — |
| Other Cashflows From Investing Activities | — | 35,375,000USD | — | -61,680,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | -23,782,000USD | 80,477,000USD | 61,680,000USD | 2,705,000USD | 1,069,000USD | 1,211,000USD |
| Sale Purchase Of Stock | — | — | -13,000USD | 2,187,000USD | 7,935,000USD | — | — |
| Change To Liabilities | — | — | — | 11,737,000USD | 1,791,000USD | 1,334,000USD | -236,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -86,360,000USD | 87,754,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | 2,143,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.